In addition, the vitamin D receptor (VDR) ligand calcipotriol can also reduce the proliferation and migration of CAFs [117], and the treatment of gastric cancer cells with calcipotriol can eliminate CAF-derived IL-8-mediated resistance to platinum oxalate by blocking the PI3K/Akt signaling pathway [118]. Here, CXCL8 is linked to gastric cancer.